Back to results
US 2022/0211643 A1Published application
Adrenaline pharmaceutical solution for an injection device
AssigneeCrossject
InventorsEric TEILLAUD, Nicolas BAUMARD, Audrey RESSEJEAC
Life of this patent
Estimating the term…
Abstract
An adrenaline pharmaceutical solution including at least: adrenaline or a pharmaceutically-acceptable salt thereof; vitamin E TPGS; a chelating agent; a solvent. The method also relates to its use in the treatment of anaphylactic shocks, cardiac arrests, asthma and cardiocirculatory distresses. The method also concerns an injection kit including an injection device and this pharmaceutical solution.
Claims15
An adrenaline pharmaceutical solution comprising at least:
- adrenaline or a pharmaceutically-acceptable salt thereof;
- D-alpha-tocopheryl polyethylene glycol succinate (hereinafter,
- abbreviated as «vitamin E TPGS»);
- a chelating agent;
- a solvent.
2 more elements
Dependencies are inferred from the claim text.